Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7462-7470

  Hu, Huiling ^a   Shioda, Tatsuo ^a   Moriya, Chikaya ^a   Xin, Xiaomi ^a   Hasan, Mohammad K ^a   Miyake, Koichi ^b   Shimada, Takashi ^b   Nagai, Yoshiyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE; GLYCOPROTEIN GP 120; MANNOSIDASE INHIBITOR; SIALIC ACID; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS SIALIDASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRINAE; PRIMATE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RETROVIRUS INFECTION; SIALYLATION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0029843589     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7462-7470.1996     Document Type: Article

References (35)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Back, N. K. T., L. Smit, J.-J. De Jong, W. Keulen, M. Schutten, J. Goudsmit, and M. Tersmette. 1994. An N-glycan within the human immunodeficiency virus type I gp120 V3 loop affects virus neutralization. Virology 199:431-438.
3. Benjouad, A., K. Mabrouk, J. C. Gluckman, and E. Fenouillet. 1994. Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoprotein. FEBS Lett. 341:244-250.
4. Bernstein, H. B., S. P. Tucker, E. Hunter, J. S. Schutzbach, and P. W. Compans. 1994. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 68:463-468.
5. + cells. Science 262:2045-2050.
6. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
7. Corfield, T. 1992. Bacterial sialidases - roles in pathogenicity and nutrition. Glycobiology 2:509-521.
8. Doe, B., K. S. Steimer, and C, M. Walker. 1994. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans. Eur. J. Immunol. 24:2369-2376.
9. Ezekowitz, R. A. B., M. Kuhlman, J. E. Groopman, and R. A. Byrn. 1989. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J. Exp. Med. 169:185-196.
10. Feizi, T., and M. Larkin. 1990. AIDS and glycosylation. Glycobiology 1:17-23.
11. Fennie, C., and L. A. Lasky. 1989. Model for intracellular folding of the human immunodeficiency virus type 1 gp120. J. Virol. 63:639-646.
12. Geyer, H., C. Holschbach, G. Hunsmann, and J. Schneider. 1988. Carbohydrates of human immunodeficiency virus. J. Biol. Chem. 263:11760-11767.
13. Gruters, R. A., J. J. Neefjes, M. Y. Tersmette, R. E. de Goede, A. Tulp, H. G. Huisman, F. Miedema, and H. L. Ploegh. 1987. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature (London) 330:74-77.
14. Kanda, T., and H. Shibuta. 1981. A temperature-sensitive mutant of Sendai virus which establishes persistent infection in Vero cells without cell crisis. Virology 108:318-324.
15. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
16. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
17. Manca, F. 1992. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J. Immunol. 148:2278-2282.
18. Meindl, P., G. Bodo, P. Palese, J. Schulman, and H. Tuppy. 1974. Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acety-ineuraminic acid. Virology 58:457-463.
19. Mizuochi, T., M. W. Spellman, M. Larkin, J. Solomon, L. J. Basa, and T. Feizi. 1988. Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem. J. 254:599-603.
20. Mizuochi, T., M. W. Spellman, M. Larkin, J. Solomon, L. J. Basa, and T. Feizi. 1988. Structural characterization by chromatographic profiling of the oligosaccharides of human immunodeficiency virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biomed. Chromatogr. 2:260-270.
21. Montefiori, D. C., W. E. Robinson, Jr., and W. M. Mitchell. 1988. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 85:9248-9252.
22. Montefiori, D. C., W. E. Robinson, Jr., and W. M. Mitchell. 1989. Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors. Antiviral Res. 11:137-146.
23. Montefiori, D. C., K. Stewart, J. M. Ahearn, J. Zhou, and J. Zhou. 1993. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J. Virol. 67:2699-2706.
24. MAC. J. Virol. 62:4691-4696.
25. Narayan, O., and J. E. Clements. 1990, Lentiviruscs, p. L571-1589. In B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Virology, 2nd ed. Raven Press, Ltd., New York.
26. Nishikawa, K., T. Morishima, T. Toyoda, T. Miyadai, T. Yokochi, T. Yoshida, and Y. Nagai. 1986. Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements. J. Virol. 60:987-993.
27. Pal, R., G. M. Hoke, and M. G. Sarngadharan. 1989. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:3384-3388.
28. Ray, P. K. 1977. Bacterial neuraminidase and altered immunological behavior of treated mammalian cells. Adv. Appl. Microbiol. 21:227-267.
29. Roggentin, P., R. Schauer, L. L. Hoyer, and E. R. Vimr. 1993. The sialidase superfamily and its spread by horizontal gene transfer. Mol. Microhiol. 9:915-921.
30. Shibata, R., T. Miura, M. Hayami, K. Ogawa, H. Sakai, T. Kiyomasu, A. Ishimoto, and A. Adachi. 1990. Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIVagm. J. Virol. 64:742-747.
31. + cells by a recombinant human immunodeficiency virus retroviral vector. J. Clin. Invest. 88:1043-1047.
32. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (London) 349:167-169.
33. Stein, B. S., and E. G. Engleman. 1990. Intracellular processing of the gp160 HIV-1 envelope precursor. J. Biol. Chem. 265:2640-2549.
34. Vimr, E. R. 1994. Microbial sialidases: does bigger always mean better? Trends Microbiol. 2:271-277.
35. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.